US SEC may appeal Ripple ruling by Oct. 7
The SEC has until October 7 to decide whether to challenge U.S. District Judge Analisa Torres' July 2023 ruling that Ripple's sale of only a portion of its XRP crypto token violated securities laws, a ruling that drew criticism from securities lawyers and other federal judges, foxbusiness reported.
The ruling was seen as a major legal victory for the fledgling crypto industry, as it sought to prove that the nascent asset class did not violate U.S. securities laws, as the SEC had argued. It also serves as a cornerstone of the legal strategy for other crypto entities, such as trading platforms Coinbase, Binance and Kraken, which are currently being sued by the commission for allegedly selling unregistered securities.
Former SEC enforcement attorney arc Powers said in an interview with Fox Business that the SEC is likely to appeal as the agency and its cryptocurrency skeptic chairman Gary Gensler are determined to exercise jurisdiction over the $2 trillion industry.
Disclosure is a cornerstone of U.S. securities law, foxbusiness said. When a company sells stock to raise money and expand its business, it must make extensive filings to provide investors with the information they need to determine whether to buy shares. And some legal experts say Judge Analisa Torres' ruling subverts that disclosure requirement.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.